Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)

Clinical trial NCT00044486 · COMPLETED

Trial details

NCT number: NCT00044486
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Myelocytic, Acute Myelodysplastic Syndromes Neutropenia

Start date: 2002-07-01
Primary completion: 2004-12-01
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.